Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability

Christina Tremblay, Shady Rahayel, Andrew Vo, Filip Morys, View ORCID ProfileGolia Shafiei, Ross D. Markello, Ziv Gan-Or, Bratislav Misic, Alain Dagher
doi: https://doi.org/10.1101/2021.06.08.21258321
Christina Tremblay
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shady Rahayel
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
2Centre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, 5400 Boul. Gouin O, H4J 1C5, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Vo
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filip Morys
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Golia Shafiei
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Golia Shafiei
Ross D. Markello
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
3Department of Human Genetics, McGill University, 3640 University Street, H3A 0C7, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bratislav Misic
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Dagher
1Montreal Neurological Institute, McGill University, 3801 University Street, H3A 2B4, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alain.dagher@mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Atrophy in multiple brain regions has been reported in the early stages of Parkinson’s Disease, but there have been few longitudinal studies. How intrinsic properties of the brain, such as anatomical connectivity, local cell type distribution and gene expression combine to determine the pattern of disease progression remains unknown. One hypothesis proposes that the disease stems from prion-like propagation of misfolded alpha-synuclein via the connectome that might cause varying degrees of tissue damage based on local properties.

Here we used MRI data from the Parkinson Progression Markers Initiative to test this model by mapping the progression of brain atrophy over one, two and four years and relating it to brain structural and functional connectivity, cell type expression and gene ontology enrichment analyses. In this longitudinal study, we derived atrophy progression maps for the three time points using deformation-based morphometry applied to T1-weighted MRI from 74 de novo Parkinson’s Disease patients (50 Men: 24 Women) and 157 healthy control participants (115 Men: 42 Women). After regressing out the expected age and sex effects associated with normal aging, we found that atrophy significantly progressed over two and four years in the caudate, nucleus accumbens, hippocampus, and the temporal, parietal, occipital and posterior cingulate cortex. This progression was shaped by both structural and functional brain connectivity. Also, the progression of atrophy was more pronounced in regions with a higher expression of genes related to synapses and was related to the prevalence of oligodendrocytes and endothelial cells.

In sum, we demonstrate that the progression of atrophy in Parkinson’s Disease is in line with the prion-like propagation hypothesis of alpha-synuclein and provide evidence that synapses may be especially vulnerable to synucleinopathy. In addition to identifying vulnerable brain regions, this study reveals different factors that may be implicated in the neurotoxic mechanisms leading to progression in Parkinson’s Disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by grants from the Michael J Fox Foundation for Parkinson's Research, the Alzheimer's Association, the Weston Brain Institute, the Canadian Institutes of Health Research and the Healthy Brains for Healthy Lives (HBHL) initiative of McGill University. SR receives a scholarship from the Fonds de Recherche du Quebec – Sante.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data used in this study were obtained from the Parkinson's progression markers initiative (PPMI), an open access database (www.ppmi-info.org/data).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

MRI data used in this article are available for download at www.ppmi-info.org/data. All other datasets and software used are available from the sources cited in the Methods. The DBM atrophy progression maps will be made available on request.

https://www.ppmi-info.org/data

  • Abbreviations

    AHBA
    Allen Human Brain Atlas
    BBB
    blood-brain barrier
    Bl
    Baseline
    CAT12
    Computational Anatomy Toolbox
    DBM
    deformation-based morphometry
    FC
    functional connectivity
    FDR
    false discovery rate
    FEW
    Family-wise error
    GDS
    Geriatric Depression Scale
    GO
    gene ontology
    GOrilla
    Gene Ontology enRIchment anaLysis and visuaLizAtion tool
    HC
    healthy control
    HVLT
    Hopkins Verbal Learning Test
    L-Dopa
    Levodopa
    MDS-UPDRS
    Movement Disorder Society Unified Parkinson Disease Rating Scale
    MNI
    Montreal Neurological Institute
    MoCA
    Montreal Cognitive Assessment
    NFL
    neurofilament light polypeptide
    PPMI
    Parkinson’s progression markers initiative
    pTFCE
    probabilistic approach for threshold-free cluster enhancement
    SD
    Standard Deviation
    SPM12
    Statistical Parametric Mapping software
    STAI
    State-Trait Anxiety Inventory
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted June 09, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability
    Christina Tremblay, Shady Rahayel, Andrew Vo, Filip Morys, Golia Shafiei, Ross D. Markello, Ziv Gan-Or, Bratislav Misic, Alain Dagher
    medRxiv 2021.06.08.21258321; doi: https://doi.org/10.1101/2021.06.08.21258321
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability
    Christina Tremblay, Shady Rahayel, Andrew Vo, Filip Morys, Golia Shafiei, Ross D. Markello, Ziv Gan-Or, Bratislav Misic, Alain Dagher
    medRxiv 2021.06.08.21258321; doi: https://doi.org/10.1101/2021.06.08.21258321

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Pathology
    Subject Areas
    All Articles
    • Addiction Medicine (216)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1097)
    • Dentistry and Oral Medicine (196)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
    • Epidemiology (9773)
    • Forensic Medicine (5)
    • Gastroenterology (481)
    • Genetic and Genomic Medicine (2313)
    • Geriatric Medicine (223)
    • Health Economics (462)
    • Health Informatics (1562)
    • Health Policy (736)
    • Health Systems and Quality Improvement (604)
    • Hematology (238)
    • HIV/AIDS (504)
    • Infectious Diseases (except HIV/AIDS) (11650)
    • Intensive Care and Critical Care Medicine (617)
    • Medical Education (238)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2144)
    • Nursing (134)
    • Nutrition (337)
    • Obstetrics and Gynecology (427)
    • Occupational and Environmental Health (518)
    • Oncology (1180)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (147)
    • Palliative Medicine (50)
    • Pathology (311)
    • Pediatrics (695)
    • Pharmacology and Therapeutics (300)
    • Primary Care Research (267)
    • Psychiatry and Clinical Psychology (2182)
    • Public and Global Health (4663)
    • Radiology and Imaging (778)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (624)
    • Rheumatology (274)
    • Sexual and Reproductive Health (226)
    • Sports Medicine (210)
    • Surgery (252)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)